<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Excessive generation of free radicals and decreased levels of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes such as <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) and catalase have been observed after brain ischemic reperfusion injury </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we have investigated the neuroprotective potential of MnTMPyP (Mn(III)tetrakis(1-<z:chebi fb="36" ids="29309">methyl</z:chebi>-4-pyridyl)<z:chebi fb="2" ids="8337">porphyrin</z:chebi> pentachloride), a SOD/Catalase mimetic in bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> model of global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in Mongolian gerbils </plain></SENT>
<SENT sid="2" pm="."><plain>Five minutes of bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> produced global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, which was evident from the neurological deficits, spontaneous motor activity and the decrease in the number of viable hippocampal CA1 neurons </plain></SENT>
<SENT sid="3" pm="."><plain>Global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was also associated with increased levels of malondialdehyde, decreased levels of SOD and catalase, and increased TUNEL (terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labeling) positive cells, indicating <z:mp ids='MP_0003674'>oxidative stress</z:mp> and DNA fragmentation </plain></SENT>
<SENT sid="4" pm="."><plain>Administration of a single dose of MnTMPyP, 1 mg/kg i.p </plain></SENT>
<SENT sid="5" pm="."><plain>(30 min before occlusion), produced no significant neuroprotection; however, 3 mg/kg i.p </plain></SENT>
<SENT sid="6" pm="."><plain>(30 min before to occlusion) produced significant reduction in neurological score, spontaneous motor activity and CA1 pyramidal neuronal damage </plain></SENT>
<SENT sid="7" pm="."><plain>MnTMPyP also attenuated the increased levels of malondialdehyde and improved the levels of SOD and catalase, and inhibited DNA fragmentation in the ischemic animals </plain></SENT>
<SENT sid="8" pm="."><plain>Multiple administration of MnTMPyP, 3 mg/kg i.p </plain></SENT>
<SENT sid="9" pm="."><plain>(three times: 30 min before, 1 h and 3 h after occlusion), produced better neuroprotection as compared to single dose administration </plain></SENT>
<SENT sid="10" pm="."><plain>This study demonstrates that the neuroprotective effect of MnTMPyP in global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is mediated through reduction in <z:mp ids='MP_0003674'>oxidative stress</z:mp> and DNA fragmentation </plain></SENT>
</text></document>